Why the slow diffusion of treatment guidelines into clinical practice?

Archives of Internal Medicine

Volumn 167, Issue 22, 2007, Pages 2394-2395

  Kotchen, Theodore A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CARDIOVASCULAR SYMPTOM; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CLINICAL RESEARCH; COMORBIDITY; DIABETES MELLITUS; DISEASE CONTROL; DISEASE COURSE; EDITORIAL; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; TREATMENT INDICATION;

ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; INFORMATION DISSEMINATION; PRACTICE GUIDELINES AS TOPIC; SURVIVAL RATE; WORLD HEALTH;

EID: 37149039013     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.22.2394     Document Type: Editorial

References (8)

1. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [published correction appears in JAMA. 2003;290(2):197]. JAMA. 2003;289(19):2560-2572.
2. Wong ND, Lopez VA, L'Italien G, Chen R, Kline SEJ, Franklin SS. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. Arch Intern Med. 2007;167(22):2431-2436.
3. Centers for Disease Control and Prevention,National Center for Health Statistics. National Health and Nutrition Examination Survey Data. Hyattsville, MD: US Dept of Health and Human Services, Centers for Disease Control and Prevention; 2004.
4. Hajjar IM, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290(2):199-206.
5. Lenfant C. Clinical research to clinical practice: lost in translation? N Engl J Med. 2003;349(9):868-874.
6. Rossouw JE, Anderson GL, Prentice RL, et al; Writing Group for the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA. 2002;288(3):321-333.
7. Zerhouni EA. Translational and clinical science: time for a new vision. N Engl J Med. 2005;353(15):1621-1623.
8. Loscalzo J. The NIH budget and the future of biomedical research. N Engl J Med. 2006;354(16):1665-1667.